ENDEFR
Home › Switzerland › SANTHERA PHARMACEUTICALS HOLDING AG

SANTHERA PHARMACEUTICALS HOLDING AG

Aktiengesellschaft (AG) · PRATTELN, Switzerland · LEI 54930035HAOFTTQH0U85
LEI lapsedgroup parent

Summary

SANTHERA PHARMACEUTICALS HOLDING AG is registered in Switzerland and entered in the “Commercial Register” under number CHE-105.388.338. Its legal form is Aktiengesellschaft (AG) – public limited company (Switzerland). SANTHERA PHARMACEUTICALS HOLDING AG is the ultimate parent of a group of 1 subsidiary in 1 country, as reported to GLEIF. GLEIF gives this reason: no known person controls the entity, for example because its shareholders are diverse. It has 1 direct subsidiary in GLEIF data; 1 of them has a lapsed LEI. The LEI was first issued on 19 Oct 2017 and the record was last updated on 31 Jul 2023. It has lapsed: renewal was due by 18 Jan 2022. GLEIF's ISIN mapping lists 1 ISIN for this LEI. AssetCensus found 1 data-quality note for this entity (see below).

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

  • The LEI has lapsed: it was due for renewal by 18 Jan 2022 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.

Company details

Legal formAktiengesellschaft (AG)
public limited company (Switzerland)
RegisterCommercial Register · Register website
Registration numberCHE-105.388.338
Registration authorityMinistry of Justice
JurisdictionSwitzerland
Registered addressHOHENRAINSTRASSE 24, 4133 PRATTELN, Switzerland
Categorycompany or other legal entity
Statusactive
LEI54930035HAOFTTQH0U85
LEI statuslapsed
LEI first issued19 Oct 2017
LEI record last updated31 Jul 2023
Next LEI renewal18 Jan 2022
Corroboration of the LEI recordfully corroborated

Group membership

SANTHERA PHARMACEUTICALS HOLDING AG this entity
SANTHERA PHARMACEUTICALS (SWITZERLAND) LTD Switzerland lapsed

Parent not reported to GLEIF

  • Direct parent: no known person controls the entity, for example because its shareholders are diverse.
  • Ultimate parent: no known person controls the entity, for example because its shareholders are diverse.

Direct subsidiaries (1)

ISINs mapped to this LEI (1)

CH1276028821

1 in the GLEIF–ANNA mapping file. The file covers ISINs issued since the mapping started, not all securities.

Other names

  • MyoContract AG · previous name
  • MyoContract Pharmaceutical Research AG · previous name
  • Santhera Pharmaceuticals AG · previous name